B
Live / Applied — Statement of use — processing complete, to examiner (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 22 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97470839
- Mark type
- Design + words
- Filed
- 22 Jun 2022
- Published for opposition
- 17 Jan 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- BridgeBio Pharma, Inc., Palo Alto, CA, US
- BridgeBio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 12 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Sept 2025 — USE AMENDMENT FILED
- 11 Mar 2026 — SOU EXTENSION 5 GRANTED
- 12 Sept 2025 — SOU EXTENSION 5 FILED
- 12 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2025 — SOU EXTENSION 4 GRANTED
- 05 Mar 2025 — SOU EXTENSION 4 FILED
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2024 — SOU EXTENSION 3 GRANTED
- 08 Aug 2024 — SOU EXTENSION 3 FILED
- 08 Aug 2024 — SOU TEAS EXTENSION RECEIVED